Exagen Statistics
Total Valuation
Exagen has a market cap or net worth of $59.10 million. The enterprise value is $60.06 million.
Important Dates
The last earnings date was Tuesday, March 11, 2025, before market open.
| Earnings Date | Mar 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Exagen has 17.64 million shares outstanding. The number of shares has increased by 2.96% in one year.
| Current Share Class | 17.64M |
| Shares Outstanding | 17.64M |
| Shares Change (YoY) | +2.96% |
| Shares Change (QoQ) | +0.95% |
| Owned by Insiders (%) | 10.25% |
| Owned by Institutions (%) | 30.39% |
| Float | 8.71M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.10 |
| Forward PS | 0.88 |
| PB Ratio | 6.19 |
| P/TBV Ratio | 6.19 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.08 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.70, with a Debt / Equity ratio of 2.41.
| Current Ratio | 2.70 |
| Quick Ratio | 2.21 |
| Debt / Equity | 2.41 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -6.10 |
Financial Efficiency
Return on equity (ROE) is -93.78% and return on invested capital (ROIC) is -21.49%.
| Return on Equity (ROE) | -93.78% |
| Return on Assets (ROA) | -16.77% |
| Return on Invested Capital (ROIC) | -21.49% |
| Return on Capital Employed (ROCE) | -43.73% |
| Revenue Per Employee | $310,844 |
| Profits Per Employee | -$84,441 |
| Employee Count | 179 |
| Asset Turnover | 1.09 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Exagen has paid $12,000 in taxes.
| Income Tax | 12,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +85.08% in the last 52 weeks. The beta is 1.40, so Exagen's price volatility has been higher than the market average.
| Beta (5Y) | 1.40 |
| 52-Week Price Change | +85.08% |
| 50-Day Moving Average | 3.78 |
| 200-Day Moving Average | 3.12 |
| Relative Strength Index (RSI) | 44.75 |
| Average Volume (20 Days) | 90,105 |
Short Selling Information
The latest short interest is 32,455, so 0.18% of the outstanding shares have been sold short.
| Short Interest | 32,455 |
| Short Previous Month | 26,688 |
| Short % of Shares Out | 0.18% |
| Short % of Float | 0.37% |
| Short Ratio (days to cover) | 0.17 |
Income Statement
In the last 12 months, Exagen had revenue of $55.64 million and -$15.12 million in losses. Loss per share was -$0.83.
| Revenue | 55.64M |
| Gross Profit | 33.11M |
| Operating Income | -13.64M |
| Pretax Income | -17.28M |
| Net Income | -15.12M |
| EBITDA | -11.91M |
| EBIT | -13.64M |
| Loss Per Share | -$0.83 |
Full Income StatementBalance Sheet
The company has $22.04 million in cash and $23.01 million in debt, giving a net cash position of -$969,000 or -$0.05 per share.
| Cash & Cash Equivalents | 22.04M |
| Total Debt | 23.01M |
| Net Cash | -969,000 |
| Net Cash Per Share | -$0.05 |
| Equity (Book Value) | 9.54M |
| Book Value Per Share | 0.54 |
| Working Capital | 22.95M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$13.28 million and capital expenditures -$515,000, giving a free cash flow of -$13.79 million.
| Operating Cash Flow | -13.28M |
| Capital Expenditures | -515,000 |
| Free Cash Flow | -13.79M |
| FCF Per Share | -$0.78 |
Full Cash Flow StatementMargins
Gross margin is 59.51%, with operating and profit margins of -24.51% and -27.17%.
| Gross Margin | 59.51% |
| Operating Margin | -24.51% |
| Pretax Margin | -27.14% |
| Profit Margin | -27.17% |
| EBITDA Margin | -21.41% |
| EBIT Margin | -24.51% |
| FCF Margin | n/a |